Fair subject selection in clinical research: formal equality of opportunity
Other content recommended for you
- Fair and equitable subject selection in concurrent COVID-19 clinical trials
- Responsibility in health care: a liberal egalitarian approach
- A Systematic review protocol on workplace equality and inclusion practices in the healthcare sector
- Genetic information, insurance and a pluralistic approach to justice
- Legitimacy in bioethics: challenging the orthodoxy
- Justice and procedure: how does “accountability for reasonableness” result in fair limit-setting decisions?
- Donor-funded research: permissible, not perfect
- Caster semenya and a level playing field
- Is it ethical to keep interim findings of randomised controlled trials confidential?
- One principle and three fallacies of disability studies
Jump to comment:
A properly worded consent form must make risks transparent but if the person has not even been asked to participate, discrimination is too easily slipping in. Even giving the reason as duty of care can be mis/used to eliminate some people - but their participation may be valuable as well as ethical. There can be an unconscious bias to avoid difficulties for researchers but discrimination will miss opportunities for the...